Design Therapeutics, Inc. - Common Stock - fluxo de caixa (NASDAQ:DSGN) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Fluxo de caixa operacional -29.38 M-51.32 M-58.56 M-43.1 M-54.36 M -54 M Fluxo de caixa de investimento -53.64 M-220.99 M52.54 M43.95 M22.91 M 7.45 M Fluxo de caixa de financiamento 379.21 M235 K724 K513 K25.74 M 45.65 M Fluxo de caixa livre -29.38 M-51.32 M-58.56 M-43.1 M-54.55 M -54.12 M

Notícias

FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer

AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

Design Therapeutics Stock Wobbles After Rare Genetic Disease Data - Design Therapeutics (NASDAQ:DSGN)

Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript

This Biotech Leader Ran Up As Much As 18% — And Then Lost It All

RBC Capital eleva preço-alvo da Design Therapeutics com dados do ensaio clínico

Design Therapeutics divulga dados do ensaio clínico de fase 1/2 para DT-216P2 na ataxia de Friedreich

Ações da Design Therapeutics disparam com dados positivos de ensaio clínico

Design Therapeutics divulga dados positivos de ensaio para tratamento de ataxia de Friedreich

Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care Stock - BillionToOne (NASDAQ:BLLN), Desi

Design Therapeutics, Inc. (DSGN) Is Up 6.92% in One Week: What You Should Know

Design Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:DSGN) 2026-04-30